Literature DB >> 14706267

Methicillin-resistant Staphylococcus aureus bacteraemia in Western Australian teaching hospitals, 1997-1999: risk factors, outcomes and implications for management.

S P Cordova1, C H Heath, D B McGechie, A D Keil, M Y Beers, T V Riley.   

Abstract

The aim of this study was to document the evolution of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia at teaching hospitals in Perth, Western Australia (WA), and determine the risk factors and outcomes of the disease. We performed a retrospective case series analysis of all laboratory-confirmed episodes of S. aureus bacteraemia at Perth teaching hospitals between 1 July 1997 and 30 June 1999 by linking laboratory data with hospitalization data from the state's Hospital Morbidity Data System. Episodes of S. aureus bacteraemia were stratified according to methicillin susceptibility and the relationship between methicillin resistance and key factors or outcomes was determined. Almost 11% of episodes of S. aureus bacteraemia (55/509) were caused by MRSA. On age-adjusted multivariate analysis, Aboriginality (RR 6.71, 95% CI 3.20-14.10, P<0.001), geriatric unit admission (RR 5.74, 95% CI 2.01-16.37, P=0.001), female sex (RR 1.88, 95% CI 1.03-3.42, P=0.04) and healthcare-associated disease (RR 1.93, 95% CI 1.01-3.70, P=0.05) were independently associated with MRSA bacteraemia. Outcomes among those with MRSA bacteraemia included death in 15 patients and re-admission for an MRSA-related complication in five. Empirical use of vancomycin needs consideration in at-risk patients in whom Gram-positive bacteraemia is suspected clinically, with prompt review of therapy once antibiotic susceptibility results are known. The rates of re-admission after discharge for MRSA bacteraemia could be used as a clinical indicator to monitor the quality of care in hospitals.

Entities:  

Mesh:

Year:  2004        PMID: 14706267     DOI: 10.1016/j.jhin.2003.10.009

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

1.  Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control study.

Authors:  D Carnicer-Pont; K A Bailey; B W Mason; A M Walker; M R Evans; R L Salmon
Journal:  Epidemiol Infect       Date:  2006-04-20       Impact factor: 2.451

2.  Epidemiology of methicillin-resistant Staphylococcus aureus bacteremia in Gaborone, Botswana.

Authors:  Sarah M Wood; Samir S Shah; Margaret Bafana; Adam J Ratner; Peter A Meaney; Kolaatamo C S Malefho; Andrew P Steenhoff
Journal:  Infect Control Hosp Epidemiol       Date:  2009-08       Impact factor: 3.254

3.  Within-host evolution of Staphylococcus aureus during asymptomatic carriage.

Authors:  Tanya Golubchik; Elizabeth M Batty; Ruth R Miller; Helen Farr; Bernadette C Young; Hanna Larner-Svensson; Rowena Fung; Heather Godwin; Kyle Knox; Antonina Votintseva; Richard G Everitt; Teresa Street; Madeleine Cule; Camilla L C Ip; Xavier Didelot; Timothy E A Peto; Rosalind M Harding; Daniel J Wilson; Derrick W Crook; Rory Bowden
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

4.  Methicillin-resistant Staphylococcus aureus, Western Australia.

Authors:  Lynne Dailey; Geoffrey W Coombs; Frances G O'Brien; John W Pearman; Keryn Christiansen; Warren B Grubb; Thomas V Riley
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

5.  Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.

Authors:  Eun-Jeong Joo; Dong Ah Park; Cheol-In Kang; Doo Ryeon Chung; Jae-Hoon Song; Sang Moo Lee; Kyong Ran Peck
Journal:  Korean J Intern Med       Date:  2018-01-20       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.